Alerts will be sent to your verified email
Verify EmailRPGLIFE
|
RPG Life Sciences
|
SMS Pharmaceuticals
|
Guj. Themis Biosyn
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Domestic Sales Growth - YoY
|
-11.18 % | n/a | n/a |
|
R&D as a % of Total Sales
|
1.11 % | 2.4 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
23.71 % | 9.71 % | 34.65 % |
|
5yr average Equity Multiplier
|
1.34 | 1.92 | 1.29 |
|
5yr Average Asset Turnover Ratio
|
1.18 | 0.64 | 0.74 |
|
5yr Avg Net Profit Margin
|
15.65 % | 7.52 % | 35.51 % |
|
Price to Book
|
6.32 | 5.15 | 14.92 |
|
P/E
|
33.24 | 41.93 | 82.58 |
|
5yr Avg Cash Conversion Cycle
|
-53.67 Days | 95.74 Days | -112.39 Days |
|
Inventory Days
|
61.98 Days | 117.18 Days | 22.82 Days |
|
Days Receivable
|
35.4 Days | 94.73 Days | 70.51 Days |
|
Days Payable
|
143.49 Days | 94.13 Days | 130.88 Days |
|
5yr Average Interest Coverage Ratio
|
30.59 | 4.95 | 216.76 |
|
5yr Avg ROCE
|
28.37 % | 12.07 % | 45.66 % |
|
5yr Avg Operating Profit Margin
|
20.94 % | 17.65 % | 47.34 % |
|
5 yr average Debt to Equity
|
0.0 | 0.54 | 0.03 |
|
5yr CAGR Net Profit
|
35.58 % | 2.03 % | 10.07 % |
|
5yr Average Return on Assets
|
17.85 % | 4.9 % | 26.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.95 % | 68.07 % | 70.86 % |
|
Share Pledged by Promoters
|
0.0 | 17.99 % | 5.44 % |
|
Change in Promoter Holding (3 Yrs)
|
0.14 % | 3.78 % | -4.13 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.04 % | 2.96 % | 1.14 % |
|
RPG Life Sciences
|
SMS Pharmaceuticals
|
Guj. Themis Biosyn
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|